Target Market Determination
Information about the target market for our financial products.
Cmglobals AU PTY LTD Target Market Determination for OTC Derivatives
| Issuer | CM (AUST) PTY LTD |
| Product | OTC Derivatives |
| Date of TMD | September 2023 |
Introduction
This is a target market determination (“TMD”) for the purposes of section 994B of the Corporations Act 2001 (Cth) (“Corporations Act”) in respect of over-the-counter derivatives (“OTC Derivatives”) issued by CM (AUST) PTY LTD (“Cmglobals”, “we”, “us”, “our”).
Cmlgobals issues OTC Derivatives in the form of contracts for difference (“CFDs”) and margin foreign exchange (“Margin FX”) contracts. Collectively, these are referred to as OTC Derivatives in this TMD.
This TMD applies to retail clients only (“Investors”).
You should also refer to the relevant Product Disclosure Statement (“PDS”) and any other legal documents on our website before deciding whether to acquire or continue to hold OTC Derivatives.
You may also consider seeking independent advice before deciding to trade OTC Derivatives.
The contents of this TMD are general information only and it's up to you to make sure the products that we offer suit your specific needs.
Product Summary
Investor Types
OTC Derivatives are leveraged financial products which are traded over-thecounter and not through a regulated market.
An OTC Derivative is an agreement to exchange the difference in the value of an underlying asset from the time a contract is opened until the time at which it is closed. An Investor does not take physical delivery of the underlying asset and there is no exchange of one currency or underlying asset for another.
OTC Derivatives are subject to significant risks, including:
- Leverage: OTC Derivatives are leveraged products. Leverage enables an Investor to gain larger exposure to a financial market while only tying up a small amount of capital. Trading with leverage means that even a small change in the market could magnify the scope for both profits and losses.
- Volatility: Derivative markets generally can be highly volatile (i.e. they move up and down in value quite quickly) so the risk that an Investor will incur losses when they trade OTC Derivatives can be substantial. Note: mandatory negative balance protection ensures that retail clients cannot lose more than the amount deposited.
- Risk of Close Out: An Investor must meet margin requirements to trade OTC Derivatives with us. This means the Investor will need to deposit enough money into their account as margin for new and existing positions and monitor their margin requirements for any open positions. An Investor risks being closed out if they don’t have enough margin on their account.
- Holding Costs: Depending on the positions held and how long they are held for, an Investor may incur holding costs. In some cases the sum of these holding costs may exceed the amount of any profits, or they could significantly increase losses.
- Counterparty Risk: Cmglobals is the issuer of OTC Derivatives subject to this TMD. This means that the Investor is dealing with Cmglobals as the counterparty to every transaction. Accordingly, the Investor is exposed to the financial and business risks of trading with Cmglobals.
Refer to our PDS for further details in relation to risks associated with OTC Derivatives.
Product Overview
| Target Market for OTC Derivatives | Investors for whom this product may be unsuitable for |
|---|---|
OTC Derivatives are often traded for different purposes and with different strategies. We consider that the target market for OTC Derivatives is an Investor who falls into one (or more) of the categories below, noting there may also be some overlap between categories:
It is sufficient for an Investor to fall within one of the categories to be within the target market for OTC Derivatives. | OTC Derivatives will generally not be suitable for:
|
Likely objectives, financial situation and needs of retail clients in the target market
We expect that trading in OTC Derivatives will likely be consistent with the likely objectives, financial situation and needs of Investors who appreciate and understand the high risk of trading with leverage and in potentially volatile market conditions and/or Investors who want to use the product for risk mitigation given the varied ways and purposes for which OTC Derivatives can be traded.
| Target Market Category | Explanation of why OTC Derivatives are likely to be consistent with the likely objectives, financial situation and needs of the target market |
|---|---|
| 1. Investors who appreciate and understand the high risk of trading with leverage and in potentially volatile market conditions |
|
| 2. Investors who use the product for risk mitigation |
|
OTC Derivatives can be a cost-effective way for Investors to speculate on the price movement of an underlying asset which might otherwise not be available to them.
OTC Derivatives are also highly regulated and have many protections for Investors, including:
- Client qualification criteria
- Leverage restrictions
- Mandatory negative balance protection
- Prohibited incentives
Distribution Conditions
| Distribution conditions, restrictions and reasons why these are appropriate |
|---|
Any distribution of OTC Derivatives by Cmglobals will be in accordance with procedures that we determine are reasonably likely to ensure that OTC Derivatives are issued to Investors who are reasonably likely to be within our target market. These procedures include:
|
Review Triggers
Cmglobals will also review the TMD where the following review triggers occur as they may suggest that the TMD is no longer appropriate:
- we become aware of a significant issuance of OTC Derivatives to Investors outside our target market;
- material changes to the OTC Derivative products result in the key attributes of the product being no longer consistent with the likely objectives, financial situation and needs of Investors in the target market;
- material changes to law or regulation affecting OTC Derivatives;
- we become aware of a significant volume of complaints from Investors in relation to the product;
- we have a material change in the distribution conditions which makes it unlikely that Investors who are issued OTC Derivatives are in the target market;
- where a distributor has reported a significant number of complaints or noted any relevant complaint trends; or
- any other relevant event or circumstance that would materially change a factor taken into account in making this TMD for OTC Derivatives.
Periodic Reviews
Reviews of the TMD will be annual, or more frequently if a review trigger occurs, commencing on the anniversary of the TMD and finishing within 4 months of that date. The first review of this TMD was triggered in September 2023.
Reporting Requirements
The following information must be provided to Cmglobals by distributors who engage in retail product distribution conduct in relation to OTC Derivatives:
| Reporting Requirement | Reporting Period | Who must report? |
|---|---|---|
| Complaints | As received Complaints related to OTC Derivatives are to be reported by distributors to Cmglobals within 5 days of receiving the complaint | All distributors |
| Investor feedback | As received Any feedback that suggests that the product may no longer consistent with an Investor’s likely objectives | All distributors |
| Significant dealing/s outside the target market | As soon as practicable, and in any case within 10 business days after becoming aware Distributors are to report date or date range of the significant dealing/s and description of the significant dealing to Cmglobals | All distributors |
CM Globals
Suite 118, 252 Russell Street, MELBOURNE VIC 3000 AUSTRALIA
Phone +61 3 6153 0261
info@cmglobals.com
